Dispatches from CPhI
Gene therapy to drive viral and biologics market, says SAFC
SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs